Perpetual Ltd
Position in ARQT — Arcutis Biotherapeutics, Inc.
CIK 1647273
SYDNEY, NEW SOUTH WALES, C3
Position in ARQT
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$29,095,206
+$7,666,303 QoQ
Shares Held
1,109,657
+22.0% QoQ
Ownership
0.883%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#27
of 269 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Perpetual Ltd holds $110,919,281 across 11 Biotechnology names. ARQT ranks #1 (26.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
1,109,657 | $29,095,206 | |
| 2 | ARGX |
Argenx SE
|
28,246 | $26,205,790 | |
| 3 | GMAB |
Genmab A/S
|
919,048 | $25,246,248 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
104,264 | $25,124,495 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,407 | $1,500,860 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,897 | $942,296 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,722 | $819,403 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
8,583 | $639,261 |
All Filings in ARQT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,095,206 | 1,109,657 | Shares | Defined | 2026-07-15 | |
| 2026-03-31 | $21,428,903 | 909,546 | Shares | Defined | 2026-04-14 | |
| 2025-12-31 | $26,444,694 | 910,630 | Shares | Defined | 2026-01-20 | |
| 2025-09-30 | $38,163,822 | 2,024,606 | Shares | Defined | 2025-10-10 | |
| 2025-06-30 | $371,810 | 26,520 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $414,772 | 26,520 | Shares | Defined | 2025-04-24 | |
| No filing history on record for this holder in this stock. | ||||||